BASI Financial Facts

Total cost of revenue: 4.08M
Diluted net income (loss) per share: -0.09
See Full Income Statement

Current portion of capital lease obligation: 272K
Accumulated deficit: -14.38M
See Full Balance Sheet

Bioanalytical Systems (BASI) Earnings

  |   Expand Research on BASI
Next EPS Date 5/16/14 *Est. EPS Growth Rate +100.0% *Last Qtr.
Average EPS % Beat Rate -125.0% Revenue Growth Rate +7.2% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
2/13/14 Q114 $0.04N/A N/A $6.22M$5.8M N/A -13.5% Details
12/24/13 Q413 $0.03N/A N/A $5.51M$6.54M N/A +12.4% Details
10/18/13 Q313 $0.07$0.01 +$0.06$5.6M$5.65M N/A +91.2% Details
5/15/13 Q213 -$0.02$0.01 -$0.03$5.16M$5.74M N/A +124.8% Details
2/14/13 Q113 $0.02-$0.03 +$0.05$5.8M$6.65M N/A +61.5% Details
12/27/12 Q412 -$0.32-$0.03 -$0.29$6.54M$7.07M N/A +108.1% Details
5/11/12 Q212 -$0.27$0.07 -$0.34$6.97M$8.88M N/A +134.2% Details
8/14/12 Q212 -$0.10-$0.14 +$0.04$7.19M$7.23M N/A +170.2% Details